Laura Otero-Ortega

11PUBLICATIONS
31CO-AUTHORS
Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Neural engineeringPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 27, 2026
Immune Checkpoint Signatures Reveal Stage-Specific Biomarkers for High-Activity Multiple Sclerosis.

MariPaz López-Molina, Gabriel Torres Iglesias, Laura Vidal

|Dec 24, 2025
Immunological Monitoring During Anti-CD20 Therapies to Predict Infection Risk and Treatment Response in Multiple Sclerosis Patients.

Gabriel Torres Iglesias, Ana Martínez-Feito, Laura Otero-Ortega

|Nov 13, 2025
Extracellular Vesicles from Poor-Outcome Intracerebral Hemorrhage Patients Reveal Limited Reparative Potential in a Preclinical Model.

Fernando Laso-García, Nerea Díaz-Gamero, Rebeca Gallego-Ruiz

|Oct 10, 2025
Extracellular Vesicles as Novel Biomarkers for Tumor Association in Intermediate-Risk Paraneoplastic Neurologic Syndromes.

Gabriel Torres Iglesias, Alba Chavarría-Miranda, MariPaz López-Molina

|Aug 14, 2025
In-Depth Characterization of L1CAM+ Extracellular Vesicles as Potential Biomarkers for Anti-CD20 Therapy Response in Relapsing-Remitting Multiple Sclerosis.

Shamundeeswari Anandan, Karina Maciak, Regina Breinbauer

|Jun 19, 2025
Extracellular Vesicle-Derived MicroRNAs as a Biomarker for Therapeutic Response in Multiple Sclerosis.

Gabriel Torres-Iglesias, MariPaz López-Molina, Rubén Ayala-Suárez

Pageof 2